Skip to main content

Ben Philpot, PhD

February 15, 2026
  We develop therapeutics (gene therapies, ASO, small molecules, CRISPR, etc.) to treat single gene neurodevelopmental disorders such as Angelman syndrome, Pitt-Hopkins syndrome, and Dup15q syndrome. We also work to treat a vision disorder–IMPG2-mediated retinitis pigmentosa.

Stephen R. Hooper, PhD

February 15, 2026
  Pediatric Neuropsychologist with interests in both psychosocial and neurocognitive measurement. Current foci include children with chronic kidney disease, extremely low birth weight, rare disorders, diabetes, and learning disabilities.

Jonathon W. Homeister MD, PhD

February 15, 2026
  Our cardiovascular research laboratory studies the glycobiology (glycoprotein- and/or glycolipid-dependent biologic processes) inherent to the pathogenesis of inflammatory vascular and blood disease processes. We are particularly interested in understanding the glycobiology of the leukocyte adhesion cascade as a critical early component of inflammatory and immune-mediated processes, including atherosclerosis. Our...

Monica Diaz, MD, MS

February 15, 2026
  Dr. Diaz’s clinical and research interests include: Multiple sclerosis, transverse myelitis, neuromyelitis optica, neurosarcoidosis, viral or antibody-mediated encephalitis, HIV-related, neurocysticercosis, post-COVID-19 neurological complications. Research Interests – Epidemiology of HIV-associated neurological conditions, multiple sclerosis and demyelinating disorders; cognitive impairment in persons with HIV or multiple sclerosis; neurological care in international...

Vimal Derebail, MD, MPH

February 15, 2026
  Areas of clinical and research focus include clinical research glomerular disease, lupus and vasculitis as well as sickle cell and sickle cell trait related kidney disease. Additional interests in thrombotic complications in glomerular disease and vasculitis. Work with translational scientists in our group and with additional collaborators in epidemiology...

Richard F. Loeser, Jr., MD

February 15, 2026
  Dr. Richard F. Loeser, MD, is the Joseph P. Archie Jr., Eminent Professor in the Division of Rheumatology, Allergy and Immunology and the Director of the Thurston Arthritis Research Center at the University of North Carolina-Chapel Hill. Dr. Loeser’s lab employs a combination of in vitro experiments using human...

Justin Milner, PhD

February 15, 2026
  Our lab focuses on developing new and exciting approaches for enhancing the efficacy of cancer immunotherapies. We utilize cutting-edge genomics, bioengineering, computational, and immunological techniques to identify molecular drivers of T cell differentiation and function in the tumor microenvironment. Our ultimate goal is to devise effective strategies for reprogramming...

Aida Lugo-Somolinos, MD

February 15, 2026
 

Wendell Yarbrough, MD, MMHC, FACS

February 15, 2026
  Dr. Yarbrough is a surgeon-scientist active in head & neck cancer research for more than two decades. Between 2012 and 2016, he served as Chief of Otolaryngology, Director of the Head & Neck Disease Center and Co-Director of the Virus and Other Infection-Associated Cancers (VOIC) Program in the Yale...

Matthew R. Vogt, MD, PhD

February 15, 2026
  We want to understand why common pediatric respiratory virus infections cause severe disease in some people. Currently we focus on picornaviruses like parechovirus, which causes sepsis and encephalitis in newborns, and enterovirus D68, which typically causes colds but rarely causes acute flaccid myelitis, a polio-like paralyzing illness in children....

Bryce Duncan, PhD

February 15, 2026
 

J. Keith Smith, MD, PhD

February 15, 2026
Dr. Smith served is the Department’s Executive Vice Chair and Professor of Radiology. Prior to this leadership position, he served as UNC Radiology’s Interim Chair from April 2018 to September. Dr. Smith’s other past departmental leadership roles include: Director of Clinical Faculty Development (2018-2019); Vice Chair of Diagnostic Services (2015-2018);...